Ticker Details
Insmed, Inc. Insmed Inc is a global biotechnology company. It is focused on developing novel therapies that focus primarily on lung diseases.
IPO Date:	June 1, 2000
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$27.47B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.60 | 3.21%
Avg Daily Range (30 D):	$3.19 | 2.86%
Avg Daily Range (90 D):	$3.20 | 2.78%

Institutional Daily Volume
Avg Daily Volume:	.89M
Avg Daily Volume (30 D):	2.42M
Avg Daily Volume (90 D):	2.83M

Trade Size
Avg Trade Size (Sh.):	118
Avg Trade Size (Sh.) (30 D):	61
Avg Trade Size (Sh.) (90 D):	64

Institutional Trades
Total Institutional Trades:	10,660
Avg Institutional Trade:	$5.38M
Avg Institutional Trade (30 D):	$7.83M
Avg Institutional Trade (90 D):	$9.08M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$13.41M
Avg Closing Trade (30 D):	$35.79M
Avg Closing Trade (90 D):	$54.2M
Avg Closing Volume:	199.27K

News

Aug 8, 2026 @ 6:15 PM Stanley Druckenmiller's Portfolio Skips Megacap Te... Source: Dave Kovaleski

Jun 12, 2026 @ 12:00 AM Nasdaq-100 Index® June 2026 Quarterly Changes Source: Nasdaq

May 7, 2026 @ 4:44 PM Nasdaq 100 Climbs Records, Oil Extends Drop As Ira... Source: Piero Cingari

Apr 8, 2026 @ 5:00 PM Interstitial Lung Disease Market to Witness Accele... Source: Delveinsight

Mar 21, 2026 @ 11:19 PM This New $193 Million Bet Targets a Biotech With $... Source: Jonathan Ponciano

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-4.1	$-.06	$-.76
Diluted EPS	$-4.1	$-.06	$-.76
Revenue	$1.14B	$425.49M	$305.96M
Gross Profit	$949.42M	$358.27M	$258.54M
Net Income / Loss	$-875.31M	$-13.24M	$-163.56M
Operating Income / Loss	$-840.62M	$-1.55M	$-153.32M
Cost of Revenue	$188.22M	$67.21M	$47.42M
Net Cash Flow	$-739.56M	$-37.42M	$71.74M
PE Ratio

Splits
Mar 03, 2011	1:10
Jul 31, 2000	1:4